Immunohistochemical Study Of Fibronectin, Tenascin and Type I Collagen In Tongue And Lip carcinomas

  • João Luiz de Miranda
  • Felipe Rodrigues de Matos
  • Frederico Santos Lages
  • Dhelfeson Willya Douglas-de-Oliveira
  • Roseana Almeida Freitas

Abstract

Aim: The aim was to compare the immunoexpression of extracellular matrix proteins in squamous cell carcinomas of tongue (SCCTo) and lower lip (SCCLi). Methods: Eleven SCCTo and 11 SCCLi were selected and examined according to Bryne’s method (1998). For immunohistochemical study utilized antibodies to fibronectin, tenascin and type I collagen. Histopathologic and immunohistochemical analysis were performed on the tumor invasive front. Results: All SCCTo were classified in high score malignant grade and all SCCLi in lower score. Fibronectin showed strong immunorreactivity in the peritumoral basement membrane (BM) in 91% of SCCTo and all cases of SCCLi, while in the tumor stroma (TS) all cases of SCCTo and SCCLi had strong intensity. Tenascin had strong expression in BM of 91% cases of SCCTo and 63.4% of SCCLi and in TS had strong expression in 91% cases of SCCTo and 54.6% of SCCLi. Type I collagen demonstrated weak immunoreactivity in the TS of 72.7% cases of SCCTo and 63.4% of SCCLi. Conclusion: These results may suggest that the strong expression of fibronectin and tenascin proteins and the weak expression of type I collagen could play a role in the invasive process of oral SCC.

References

1. Aparna M, Rao L, Kunhikatta V, Radhakrishnan R. The role of MMP-2 and MMP-9 as prognostic
markers in the early stages of tongue squamous cell carcinoma. J Oral Pathol Med. 2015
May;44(5):345-52. doi: 10.1111/jop.12245.
2. Bsoul SA, Huber MA, Terezhalmy GT Squamous cell carcinoma of the oral tissues: a comprehensive
review for oral healthcare providers. J Contemp Dent Pract. 2005 Nov 15;6(4):1-16.
3. Kamarajan P, Garcia-Pardo A, D’Silva NJ, Kapila YL. The CS1 segment of fibronectin is involved in
human OSCC pathogenesis by mediating OSCC cell spreading, migration, and invasion. BMC Cancer.
2010 Jun 25;10:330. doi: 10.1186/1471-2407-10-330.
4. Metwaly H, Maruyama S, Yamazaki M, Tsuneki M, Abé T, Jen KY, et al. Parenchymal-stromal
switching for extracellular matrix production on invasion of oral squamous cell carcinoma. Hum
Pathol. 2012 Nov;43(11):1973-81. doi: 10.1016/j.humpath.2012.02.006.
5. Bodner L, Manor E, Friger MD, van der Waal I. Oral squamous cell carcinoma in patients twenty years
of age or younger--review and analysis of 186 reported cases. Oral Oncol. 2014 Feb;50(2):84-9.
doi: 10.1016/j.oraloncology.2013.11.001.
6. Qi G, Ogawa I, Kudo Y, Miyauchi M, Siriwardena BS, Shimamoto F, et al. Aurora-B expression and its
correlation with cell proliferation and metastasis in oral cancer. Virchows Arch. 2007 Mar;450(3):297-302.
7. Siriwardena BS, Kudo Y, Ogawa I, Udagama MN, Tilakaratne WM, Takata T. VEGF-C is associated with
lymphatic status and invasion in oral cancer. J Clin Pathol. 2008 Jan;61(1):103-8.
8. Gallo O, Masini E, Bianchi B, Bruschini L, Paglierani M, Franchi A. Prognostic significance of
cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum
Pathol. 2002 Jul;33(7):708-14.
9. Vigneswaran N, Zhao W, Dassanayake A, Muller S, Miller DM, Zacharias W. Variable expression of
cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Hum
Pathol. 2000 Aug;31(8):931-7.
10. Siriwardena BS, Tilakaratne A, Amaratunga EA, Udagama MN, Ogawa I, Kudo Y, et al. Analysis of
histopathological and immunohistochemical differences of oral squamous cell carcinoma in young
and old patients in Sri Lanka. J Oral Pathol Med. 2007 Jul;36(6):357-62.
11. Thorup AK, Reibel J, Schiodt M, Stenersen TC, Therkildsen MH, Carter WG, et al. Can alterations
in integrin and laminin-5 expression be used as markers of malignancy? APMIS. 1998
Dec;106(12):1170-80.
12. Pereira AL, Veras SS, Silveira EJ, Seabra FR, Pinto LP, Souza LB, et al. The role of matrix extracellular
proteins and metalloproteinases in head and neck carcinomas: an updated review. Braz J
Otorhinolaryngol. 2005 Jan-Feb;71(1):81-6.
13. Foda HD, Zucker S. Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. Drug
Discov Today. 2001 May 1;6(9):478-482.
14. Thomas GJ, Speight PM. Cell adhesion molecules and oral cancer. Crit Rev Oral Biol Med.
2001;12(6):479-98.
15. Kosmehl H, Berndt A, Katenkamp D. Molecular variants of fibronectin and laminin: structure,
physiological occurrence and histopathological aspects. Virchows Arch. 1996 Dec;429(6):311-22.
16. Chiquet-Ehrismann R, Hagios C, Schenk S. The complexity in regulating the expression of tenascins.
Bioessays. 1995 Oct;17(10):873-8.
17. Ronnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to
malignant breast: importance of the stromal reaction. Physiol Rev. 1 996 Jan;76(1):69-125.
18. Tiitta O, Happonen RP, Virtanen I, Luomanen M. Distribution of tenascin in oral premalignant lesions
and squamous cell carcinoma. J Oral Pathol Med. 1994 Nov;23(10):446-50.
19. Tuxhorn JA, Ayala GE, Rowley DR. Reactive stroma in prostate cancer progression. J Urol. 2001
Dec;166(6):2472-83.
20. Jacobs TW, Schnitt SJ, Tan X, Brown LF. Radial scars of the breast and breast carcinomas have
similar alterations in expression of factors involved in vascular stroma formation. Hum Pathol. 2002
Jan;33(1):29-38.
21. van Kempen LC, Rijntjes J, Claes A, Blokx WA, Gerritsen MJ, Ruiter DJ, et al. Type I collagen synthesis
parallels the conversion of keratinocytic intraepidermal neoplasia to cutaneous squamous cell
carcinoma. J Pathol. 2004 Nov;204(3):333-9.
22. Dantas DD, Ramos CC, Costa AL, Souza LB, Pinto LP. Clinical-pathological parameters in squamous
cell carcinoma of the tongue. Braz Dent J. 2003;14(1):22-5.
23. Cruz MC, Pereira AL, Lopes FF, Nonaka CF, Silva RR, Freitas R de A, et al. Immunohistochemical
expression of E-cadherin and CD44v6 in squamous cell carcinomas of the lower lip and tongue. Braz
Dent J. 2009;20(1):64-9.
24. Qaisi M, Vorrasi J, Lubek J, Ord R. Multiple primary squamous cell carcinomas of the oral cavity.
J Oral Maxillofac Surg. 2014 Aug;72(8):1511-6. doi: 10.1016/j.joms.2014.03.012.
25. Bryne M. Is the invasive front of an oral carcinoma the most important area for prognostication? Oral
Dis. 1998;4(2):70-7.
26. da Silveira EJ, Miguel MC, Lima KC, Freitas Rde A, de Morais ML, Queiroz LM. Analysis of
local immunity in squamous cell carcinoma of the tongue and lower lip. Exp Mol Pathol. 2010
Feb;88(1):171-5. doi: 10.1016/j.yexmp.2009.11.009.
27. Lin CW, Sun MS, Wu HC. Podocalyxin-like 1 is associated with tumor aggressiveness and metastatic
gene expression in human oral squamous cell carcinoma. Int J Oncol. 2014 Aug;45(2):710-8.
doi: 10.3892/ijo.2014.2427..
28. Al-Rajhi N, Khafaga Y, El-Husseiny J, Saleem M, Mourad W, Al-Otieschan A, et al. Early stage
carcinoma of oral tongue: prognostic factors for local control and survival. Oral Oncol. 2000 Nov;
36(6):508-14.
29. Kerdpon D, Sriplung H. Factors related to advanced stage oral squamous cell carcinoma in southern
Thailand. Oral Oncol. 2001 Apr; 37(3):216-21.
30. Chen YW, Yu EH, Wu TH, Lo WL, Li WY, Kao SY. Histopathological factors affecting nodal metastasis
in tongue cancer: analysis of 94 patients in Taiwan. Int J Oral Maxillofac Surg. 2008 Oct;37(10):912-6.
doi: 10.1016/j.ijom.2008.07.014.
31. Shrestha P, Sumitomo S, Lee CH, Nagahara K, Kamegai A, Yamanaka T, et al. Tenascin: growth and
adhesion modulation--extracellular matrix degrading function: an in vitro study. Eur J Cancer B Oral
Oncol. 1996 Mar;32B(2):106-13.
32. Larsen M, Artym VV, Green JA, Yamada KM. The matrix reorganized: extracellular matrix remodeling
and integrin signaling. Curr Opin Cell Biol. 2006 Oct;18(5):463-71.
33. Orend G, Chiquet-Ehrismann R. Tenascin-C induced signaling in cancer. Cancer Lett. 2006
Dec;244(2):143-63.
34. Lyons AJ, Bateman AC, Spedding A, Primrose JN, Mandel U. Oncofetal fibronectin and oral
squamous cell carcinoma. Br J Oral Maxillofac Surg. 2001 Dec;9(6):471-7.
35. Zidar N, Gale N, Kambic V, Fischinger J. Expression of tenascin and fibronectin in benign
epithelial hyperplastic lesions and squamous carcinoma of the larynx. Anticancer Res.
2001 Jan-Feb;21(1A):451-4.
36. Yoshida T, Yoshimura E, Numata H, Sakakura Y, Sakakura T. Involvement of tenascin-C in proliferation
and migration of laryngeal carcinoma cells. Virchows Arch. 1999 Nov;435(5):496-500.
37. Juhasz A, Bardos H, Repassy G, Adany R. Characteristic distribution patterns of tenascin in laryngeal
and hypopharyngeal cancers. Laryngoscope. 2000 Jan;110(1):84-92.
38. Sekiguchi T, Noguchi M, Nakamori K, Kohama G-I. Clinical significance of interstitial collagen
deposition at the invading edge in oral cancer: immunohistochemistry for type I collagen. Int J Clin
Oncol. 1997 Mar;2(1):21-8.
39. Kosmehl H, Berndt A, Strassburger S, Borsi L, Rousselle P, Mandel U, et al. Distribution of laminin
and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma. Br J Cancer. 1999
Nov;81(6):1071-9.
40. Lyons AJ, Jones J. Cell adhesion molecules, the extracellular matrix and oral squamous carcinoma.
Int J Oral Maxillofac Surg. 2007 Aug;36(8):671-9.
41. Ryu MH, Park HM, Chung J, Lee CH, Park HR. Hypoxia-inducible factor-1alpha mediates oral
squamous cell carcinoma invasion via upregulation of alpha5 integrin and fibronectin. Biochem
Biophys Res Commun. 2010 Feb 26;393(1):11-5. doi: 10.1016/j.bbrc.2010.01.060.
42. Arduino PG, Carrozzo M, Pagano M, Broccoletti R, Scully C, Gandolfo S. Immunohistochemical
expression of basement membrane proteins of verrucous carcinoma of the oral mucosa. Clin Oral
Investig. 2010 Jun;14(3):297-302. doi: 10.1007/s00784-009-0296-y.
43. Araujo VC, Furuse C, Cury PR, Altemani A, Alves VA, de Araujo NS. Tenascin and fibronectin
expression in carcinoma ex pleomorphic adenoma. Appl Immunohistochem Mol Morphol. 2008
Jan;16(1):48-53.
44. Ohtsuka M, Yamamoto H, Oshiro R, Takahashi H, Masuzawa T, Uemura M, et al. Concurrent
expression of C4.4A and Tenascin-C in tumor cellsrelates to poor prognosis of esophageal
squamous cell carcinoma. Int J Oncol. 2013 Aug;43(2):439-46. doi: 10.3892/ijo.2013.1956.
45. Nagaharu K, Zhang X, Yoshida T, Katoh D, Hanamura N, Kozuka Y, et al. Tenascin C induces
epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion
kinase phosphorylation in human breast cancer cells. Am J Pathol. 2011 Feb;178(2):754-63.
doi: 10.1016/j.ajpath.2010.10.015.
46. Orend G, Chiquet-Ehrismann R. Adhesion modulation by antiadhesive molecules of the extracellular
matrix. Exp Cell Res. 2000 Nov;261(1):104-10.
47. Franz M, Hansen T, Borsi L, Geier C, Hyckel P, Schleier P, et al. A quantitative co-localization analysis of
large unspliced tenascin-C(L) and laminin-5/gamma2-chain in basement membranes of oral squamous
cell carcinoma by confocal laser scanning microscopy. J Oral Pathol Med. 2007;36(1):6-11.
48. Wang Z, Han B, Zhang Z, Pan J, Xia H. Expression of angiopoietin-like 4 and tenascin C but not
cathepsin C mRNA predicts prognosis of oral tongue squamous cell carcinoma. Biomarkers. 2010
Feb;15(1):39-46. doi: 10.3109/13547500903261362.
49. Wilson DF, Jiang DJ, Pierce AM, Wiebkin OW. Oral cancer: role of the basement membrane in
invasion. Aust Dent J. 1999;44(2):93-7.
50. Allon I, Vered M, Buchner A, Dayan D. Stromal differences in salivary gland tumors of a common
histopathogenesis but with different biological behavior: a study with picrosirius red and polarizing
microscopy. Acta Histochem. 2006;108(4):259-64.
51. Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ. Regulation of cell invasion and morphogenesis in a
three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases. 1, 2, and 3.
J Cell Biol. 2000 Jun;149(6):1309-23.
52. Menke A, Philippi C, Vogelmann R, Seidel B, Lutz MP, Adler G, et al. Down-regulation of E-cadherin
gene expression by collagen type I and type III in pancreatic cancer cell lines. Cancer Res. 2001
Apr;61(8):3508-17.
53. Takayama S, Hatori M, Kurihara Y, Kinugasa Y, Shirota T, Shintani S. Inhibition of TGF-beta1
suppresses motility and invasiveness of oral squamous cell carcinoma cell lines via modulation of
integrins and down-regulation of matrix-metalloproteinases. Oncol Rep. 2009 Jan;21(1):205-10.
54. Monteiro LS, Delgado ML, Ricardo S, Garcez F, do Amaral B, Pacheco JJ, et al. EMMPRIN expression
in oral squamous cell carcinomas: correlation with tumor proliferation and patient survival. Biomed
Res Int. 2014;2014:905680. doi: 10.1155/2014/905680.
Published
2017-11-30
How to Cite
MIRANDA, João Luiz de et al. Immunohistochemical Study Of Fibronectin, Tenascin and Type I Collagen In Tongue And Lip carcinomas. Brazilian Journal of Oral Sciences, [S.l.], p. e17034, nov. 2017. ISSN 1677-3225. Available at: <https://www.fop.unicamp.br/bjos/index.php/bjos/article/view/167>. Date accessed: 15 july 2019. doi: https://doi.org/10.20396/bjos.v16i1.8651061.
Section
Original Research